Dual Energy Spectral CT of Focal Liver Lesions in Advanced Cirrhosis: Early Experience

Size: px
Start display at page:

Download "Dual Energy Spectral CT of Focal Liver Lesions in Advanced Cirrhosis: Early Experience"

Transcription

1 Dual Energy Spectral CT of Focal Liver Lesions in Advanced Cirrhosis: Early Experience William P. Shuman MD, FACR University of Washington SCBTMR Annual Course Washington DC, October 23-26, 2011

2 Conflict of Interest Statement I administer a grant from GE Healthcare which supports clinical investigations in body CT No support for equipment or salaries

3 Model for End-stage Liver Disease MELD Score (6 40 points) Mayo Clinic 2000 Used to stratify patients waiting for liver transplant by medical urgency Based on lab data creatinine, tot. bilirubin, ratio

4 Model for End-stage Liver Disease MELD Score (6-40) No exception for stage 1 HCC (< 2cm) Exception for patients with stage T2 HCC Granted 24 extra points Goal: Waiting time for HCC = non-hcc Drop-out rates equal

5 UCSF-Expanded MELD Criteria Now (2010) includes Stage 3a by CT imaging criteria - hypervascular lesion in patients with end stage liver disease: Single lesion < 2 cm 6.5 cm 2-3 lesions each 4.5 cm total lesion diameter 8 cm No macrovascular invasion on CT Pomfret EA, Liver Transpl 2010; 16:262

6 Single Energy CT Early detection of small lesions is imperfect MR sensitivity outperforms CT by 10 15% Characterization of small lesions into cyst versus small tumor is difficult HU unreliable due to partial volume

7 Dual Energy: Potential Liver Applications Enhance the subtle lesion Tumor versus cyst Eliminate unenhanced phase Focal fat, Iron deposition Response to Y-90

8 Dual Energy Liver CT: History First published in 1980, Brit. Med. J. R.W.G. Chapman and Gram Bydder Dual Energy CT for liver iron content in hemochromatosis EMI and 110 kvp 20 seconds per slice CT estimates of iron content correlated closely with chemical analysis of biopsies

9 Dual Energy Liver CT: 2008 R. Nelson, MDCT, Las Vegas, 5/15/08

10 Dual Energy Liver CT: kvp 140 kvp D. Marin et al, Radiology, 2009

11 Dual Energy: The Big Questions Might late-arterial stage dual energy CT in patients with end stage liver disease improve hypervascular lesion (HCC) - Conspicuity of individual lesions Number of lesions detected Accuracy of measurements Characterization of lesions (washout)

12 DECT of Hypervasc. Liver Lesions 40 patients with HCC, 135 lesions (2011) 80 kvp 140 Averaged Mean # lesions Total # lesions HU (ave) CNR Image Quality poor fair excellent Altenbernd A, et al, Eur Radiology : 738

13

14 Dual- vs. Single- Energy CT: Dose University of Washington experience: GE HD 750 with GSI CT of liver Single: ACTM NI=36, ASIR 40% DE GSI: ACTM NI=25, ASIR 30% (Fixed) Dual energy runs 15% higher dose than our routine clinical scanning (NI = 36) But user variable ASIR % coming

15 kev

16 Dual Energy Spectral Imaging: HCC Water only Iodine only

17 Dual Energy Spectral Imaging: HCC 70 kev

18 Dual Energy Spectral Imaging: HCC 40 kev 130 kev

19 Dual Energy Spectral Imaging: HCC 40 kev 60 kev

20 Dual Energy Spectral Imaging: HCC Water Only Iodine Only

21 Dual Energy Spectral Imaging: HCC 40 kev 110 kev

22 Dual Energy Spectral Imaging: HCC 40 kev 80 kev

23

24 40 kev 67 kev 50 kev 77 kev

25 Spectral GSI and Portal Venography 30 patients with portal hypertension 140 monochromatic plus polychromatic image sets Objective CNR and subjective image quality Optimal CNR at 51 kev 100% higher contrast than 120 kvp but 30% more noise Subjective image quality scores statistically best at 51 kev Zhao et al, Euro J. Radiol, 2011

26 51 kev 120 kvp Zhao et al, Euro J Radiol 2011

27 kev vs. CNR of Iodine : 51 kev Portal Vein (Zhao, EJR) Hypervasc. Liver Lesion (Mitsumori)

28 40 kev 51 kev 70 kev 77 kev

29 Hypodense Liver Lesions: Met vs. Cyst GSI Projection Based Dual Energy Hypodense Liver Lesions Santamaria-Pang, Hara, et al, Proc SPIE, 2010

30 Liver Fat Distribution and Quantification GSI Projection Based Dual Energy Kriston, Silva, Sahani, et al, SPIE 2010

31 Conclusion Dual energy spectral CT images of the liver show promise for improving focal lesion detection and characterization in cirrhosis. Impact on lesion staging - research Optimal kev may improve sensitivity May lead to earlier tumor detection May improve characterization of lesions

Dual Energy CT Aortography: Can We Reduce Iodine Dose??

Dual Energy CT Aortography: Can We Reduce Iodine Dose?? Dual Energy CT Aortography: Can We Reduce Iodine Dose?? William P. Shuman MD, FACR FSCBTMR Department of Radiology University of Washington SCBTMR Annual Course Boston, October 10, 2012 Conflict of Interest

More information

Dual Energy CT of the Liver

Dual Energy CT of the Liver 34th Annual Course October 2011 Washington, DC Dual Energy CT of the Liver Vassilios Raptopoulos, MD Beth Israel Deaconess Medical Center Harvard Medical School Dual Energy CT (DECT) Different materials

More information

Liver, Liver Fat, Fibrosis and HCC Screening with DECT

Liver, Liver Fat, Fibrosis and HCC Screening with DECT Liver, Liver Fat, Fibrosis and HCC Screening with DECT Dushyant Sahani, M.D Director of CT Associate Professor of Radiology Massachusetts General Hospital Harvard Medical School Email-dsahani@partners.org

More information

Gemstone Spectral Imaging quantifies lesion characteristics for a confident diagnosis

Gemstone Spectral Imaging quantifies lesion characteristics for a confident diagnosis GE Healthcare Gemstone Spectral Imaging quantifies lesion characteristics for a confident diagnosis CT clinical case study lesion characterization Desiree Morgan, MD Vice Chair of Clinical Research Professor

More information

Dual-Energy CT: The Technological Approaches

Dual-Energy CT: The Technological Approaches Dual-Energy CT: The Technological Approaches Dushyant Sahani, M.D Director of CT Associate Professor of Radiology Massachusetts General Hospital Harvard Medical School Email-dsahani@partners.org Disclosure

More information

8/3/2016. Consultant for / research support from: Astellas Bayer Bracco GE Healthcare Guerbet Medrad Siemens Healthcare. Single Energy.

8/3/2016. Consultant for / research support from: Astellas Bayer Bracco GE Healthcare Guerbet Medrad Siemens Healthcare. Single Energy. U. Joseph Schoepf, MD Prof. (h.c.), FAHA, FSCBT-MR, FNASCI, FSCCT Professor of Radiology, Medicine, and Pediatrics Director, Division of Cardiovascular Imaging Consultant for / research support from: Astellas

More information

Innovations in HCC Imaging: MDCT/MRI

Innovations in HCC Imaging: MDCT/MRI Innovations in HCC Imaging: MDCT/MRI Anthony E. Cheng, M.D. Cardinal MRI Center Cardinal Santos Medical Center, Wilson Street, San Juan Innovations in HCC Imaging: Goals/Objectives MDCT/MRI Learn the diagnostic

More information

Fused monochromatic imaging acquired by single source dual energy CT in hepatocellular carcinoma during arterial phase: an initial experience

Fused monochromatic imaging acquired by single source dual energy CT in hepatocellular carcinoma during arterial phase: an initial experience Original Article Fused monochromatic imaging acquired by single source dual energy CT in hepatocellular carcinoma during arterial phase: an initial experience Shun-Yu Gao, Xiao-Peng Zhang, Yong Cui, Ying-Shi

More information

Comparison of gastric vascular anatomy by monochromatic and polychromatic dual-energy spectral computed tomography imaging

Comparison of gastric vascular anatomy by monochromatic and polychromatic dual-energy spectral computed tomography imaging Research Report Comparison of gastric vascular anatomy by monochromatic and polychromatic dual-energy spectral computed tomography imaging Journal of International Medical Research 2014, Vol. 42(1) 26

More information

HEPATO-BILIARY IMAGING

HEPATO-BILIARY IMAGING HEPATO-BILIARY IMAGING BY MAMDOUH MAHFOUZ MD PROF.OF RADIOLOGY CAIRO UNIVERSITY mamdouh.m5@gmail.com www.ssregypt.com CT ABDOMEN Indications Patient preparation Patient position Scanogram Fasting 4-6 hours

More information

Imaging of liver and pancreas

Imaging of liver and pancreas Imaging of liver and pancreas.. Disease of the liver Focal liver disease Diffusion liver disease Focal liver disease Benign Cyst Abscess Hemangioma FNH Hepatic adenoma HCC Malignant Fibrolamellar carcinoma

More information

Acknowledgments. A Specific Diagnostic Task: Lung Nodule Detection. A Specific Diagnostic Task: Chest CT Protocols. Chest CT Protocols

Acknowledgments. A Specific Diagnostic Task: Lung Nodule Detection. A Specific Diagnostic Task: Chest CT Protocols. Chest CT Protocols Personalization of Pediatric Imaging in Terms of Needed Indication-Based Quality Per Dose Acknowledgments Duke University Medical Center Ehsan Samei, PhD Donald Frush, MD Xiang Li PhD DABR Cleveland Clinic

More information

Role of DE-CT in Oncology

Role of DE-CT in Oncology Role of DE-CT in Oncology Dushyant Sahani, M.D Director of CT Associate Professor of Radiology Massachusetts General Hospital Harvard Medical School Email-dsahani@partners.org Disclosure Research Grant

More information

Emerging Applications in Musculoskeletal CT Imaging

Emerging Applications in Musculoskeletal CT Imaging Emerging pplications in Musculoskeletal CT Imaging y K Murali MD(RD), PDCC, Director of Interventional Radiology, G. Francis DMRD, DN (RD), Consultant Radiologist, and R. Madan, MS, MD, Consultant Radiologist,

More information

TREATMENT FOR HCC AND CHOLANGIOCARCINOMA. Shawn Pelletier, MD

TREATMENT FOR HCC AND CHOLANGIOCARCINOMA. Shawn Pelletier, MD TREATMENT FOR HCC AND CHOLANGIOCARCINOMA Shawn Pelletier, MD Treatment for HCC Treatment strategies Curative first line therapy Thermal ablation vs Resection vs Transplant Other first line therapies TACE

More information

Selection Criteria and Insertion of SIRT into HCC Treatment Guidelines

Selection Criteria and Insertion of SIRT into HCC Treatment Guidelines Selection Criteria and Insertion of SIRT into HCC Treatment Guidelines 2 nd Asia Pacific Symposium on Liver- Directed Y-90 Microspheres Therapy 1st November 2014, Singapore Pierce Chow FRCSE PhD SIRT in

More information

Optimal Monochromatic Energy Levels in Spectral CT Pulmonary Angiography for the Evaluation of Pulmonary Embolism

Optimal Monochromatic Energy Levels in Spectral CT Pulmonary Angiography for the Evaluation of Pulmonary Embolism Optimal Monochromatic Energy Levels in Spectral CT Pulmonary Angiography for the Evaluation of Pulmonary Embolism Jiejun Cheng., Yan Yin., Huawei Wu*, Qing Zhang, Jia Hua, Xiaolan Hua, Jianrong Xu* Department

More information

Dual-Energy CT Applications in Radiation Therapy

Dual-Energy CT Applications in Radiation Therapy THE UNIVERSITY OF WISCONSIN MADISON Dual-Energy CT Applications in Radiation Therapy - Jessica Miller 1 Disclosures Funding provided by Siemens Medical 2 Learning objectives General principles of dual

More information

ASU-Mayo Clinic Imaging Informatics Laboratory (AMIIL)

ASU-Mayo Clinic Imaging Informatics Laboratory (AMIIL) ASU-Mayo Clinic Imaging Informatics Laboratory (AMIIL) 1 ASU-Mayo Clinic Imaging Informatics Laboratory (AMIIL) http://amiil.engineering.asu.edu/ Focus Area I: Imaging-centered data analytics for better

More information

Contrast-Enhanced Digital Mammography

Contrast-Enhanced Digital Mammography 2015 ARRS Breast Symposium Contrast-Enhanced Digital Mammography John Lewin, M.D. Diversified Radiology of Colorado CEDM - Outline History Technique Literature Review / Cases Clinical Status Inexpensive,

More information

Ultrasound. Computed tomography. Case studies. Utility of IQon Spectral CT in. cardiac imaging

Ultrasound. Computed tomography. Case studies. Utility of IQon Spectral CT in. cardiac imaging Ultrasound Computed tomography Case studies Utility of IQon Spectral CT in cardiac imaging Cardiac imaging is a challenging procedure where it is necessary to image a motion-free heart. This requires a

More information

ESUR 2018, Sept. 13 th.-16 th., 2018 Barcelona, Spain

ESUR 2018, Sept. 13 th.-16 th., 2018 Barcelona, Spain ESUR 2018, Sept. 13 th.-16 th., 2018 Barcelona, Spain OUR APPROACH Incidental adrenal nodule/mass Isaac R Francis, M.B;B.S University of Michigan, Ann Arbor, Michigan Disclosures None (in memory) M Korobkin,

More information

Customizing Contrast Injection for Body MDCT: Algorithmic Approach

Customizing Contrast Injection for Body MDCT: Algorithmic Approach Customizing Contrast Injection for Body MDCT: Algorithmic Approach Lincoln L. Berland, M.D., F.A.C.R. University of Alabama at Birmingham Before Contrast Prep and Hydration Hydration single most important

More information

Hepatobiliary Contrast Agents

Hepatobiliary Contrast Agents Hepatobiliary Contrast Agents SCBT/MR Annual Meeting Salt Lake City September 21, 2016 Scott B. Reeder, MD, PhD Department of Radiology University of Wisconsin Madison, WI Disclosures University of Wisconsin-Madison

More information

HCC and mass effect. Hepatocellular cancer: what if the AFP is rising but no lesion seen on imaging? What you need to know about AFP.

HCC and mass effect. Hepatocellular cancer: what if the AFP is rising but no lesion seen on imaging? What you need to know about AFP. Hepatocellular cancer: what if the AFP is rising but no lesion seen on imaging? Arun J Sanyal M.B.B.S., M.D. Charles Caravati Professor of Medicine Virginia Commonwealth University Imaging features used

More information

40 th Annual Meeting of the SCBT/MR

40 th Annual Meeting of the SCBT/MR Liver Fat and Iron Quantification 40 th Annual Meeting of the SCBT/MR Nashville, TN September 11, 2017 Scott B. Reeder, MD, PhD 100% 0% Department of Radiology University of Wisconsin Madison, WI Disclosures

More information

Surveillance for Hepatocellular Carcinoma

Surveillance for Hepatocellular Carcinoma Surveillance for Hepatocellular Carcinoma Marion G. Peters, MD John V. Carbone, MD, Endowed Chair Professor of Medicine Chief of Hepatology Research University of California San Francisco Recorded on April

More information

The Focal Hepatic Lesion: Radiologic Assessment

The Focal Hepatic Lesion: Radiologic Assessment The Focal Hepatic Lesion: Radiologic Assessment Kevin Kuo, Harvard Medical School Year III Our Patient: PS 67 y/o female w/ long history of alcohol use Drinking since age 18, up to one bottle of wine/day

More information

Les Outils Cliniques de Demain en Scanner Cardiaque. Cardiaque Status en ECR 2018 From Diagnosis to Prognosis

Les Outils Cliniques de Demain en Scanner Cardiaque. Cardiaque Status en ECR 2018 From Diagnosis to Prognosis ECR 2018 From Diagnosis to Prognosis ECR 2018 From Diagnosis to Prognosis Thursday, March 1, 2018/08:30-10:00/Room N Les Outils Cliniques de Demain en Scanner Cardiaque Cardiaque Status en 2018 Rodrigo

More information

Anatomical and Functional MRI of the Pancreas

Anatomical and Functional MRI of the Pancreas Anatomical and Functional MRI of the Pancreas MA Bali, MD, T Metens, PhD Erasme Hospital Free University of Brussels Belgium mbali@ulb.ac.be Introduction The use of MRI to investigate the pancreas has

More information

LIVER IMAGING TIPS IN VARIOUS MODALITIES. M.Vlychou, MD, PhD Assoc. Professor of Radiology University of Thessaly

LIVER IMAGING TIPS IN VARIOUS MODALITIES. M.Vlychou, MD, PhD Assoc. Professor of Radiology University of Thessaly LIVER IMAGING TIPS IN VARIOUS MODALITIES M.Vlychou, MD, PhD Assoc. Professor of Radiology University of Thessaly Hepatocellular carcinoma is a common malignancy for which prevention, screening, diagnosis,

More information

Alice Fung, MD Oregon Health and Science University

Alice Fung, MD Oregon Health and Science University Alice Fung, MD Oregon Health and Science University Disclosure Comments The speaker Alice Fung, MD Has relevant financial relationships to disclose. Received honorarium from (Guerbet). This individual

More information

Hepatocellular Carcinoma: A major global health problem. David L. Wood, MD Interventional Radiology Banner Good Samaritan Medical Center

Hepatocellular Carcinoma: A major global health problem. David L. Wood, MD Interventional Radiology Banner Good Samaritan Medical Center Hepatocellular Carcinoma: A major global health problem David L. Wood, MD Interventional Radiology Banner Good Samaritan Medical Center Hepatocellular Carcinoma WORLDWIDE The #2 Cancer Killer Overall cancer

More information

Compute-aided Differentiation of Focal Liver Disease in MR Imaging

Compute-aided Differentiation of Focal Liver Disease in MR Imaging 1063 Compute-aided Differentiation of Focal Liver Disease in MR Imaging Xuejun Zhang a, Masayuki Kanematsu b, Hiroshi Fujita c, Takeshi Hara c, Hiroshi Kondo b, Xiangrong Zhou c, Wenguang Li a and Hiroaki

More information

State of the Art Imaging for Hepatic Malignancy: My Assignment

State of the Art Imaging for Hepatic Malignancy: My Assignment State of the Art Imaging for Hepatic Malignancy: My Assignment CT vs MR vs MRCP Which one to choose for HCC vs Cholangiocarcinoma What special protocols to use for liver tumors Role of PET and Duplex US

More information

Dual-Energy 101: Principles, Methods and Dose

Dual-Energy 101: Principles, Methods and Dose Dual-Energy 101: Principles, Methods and Dose Juan Carlos Ramirez-Giraldo, Ph.D Staff Scien2st, Collabora2ons Manager SE Region ISCT San Francisco, 2017 Siemens Medical Solu2ons USA, Inc., 2017 Page 1

More information

ENTEROCOLITIDES CAN YOU TELL THEM APART ON MDCT? Richard M. Gore, MD North Shore University Medical Center University of Chicago Evanston, Illinois

ENTEROCOLITIDES CAN YOU TELL THEM APART ON MDCT? Richard M. Gore, MD North Shore University Medical Center University of Chicago Evanston, Illinois ENTEROCOLITIDES CAN YOU TELL THEM APART ON MDCT? Richard M. Gore, MD North Shore University Medical Center University of Chicago Evanston, Illinois SCBT/MR 2010 San Diego, California March 8, 2010 13:40-14:00

More information

ADRENAL LESIONS 10/09/2012. Adrenal + lesion. Introduction. Common causes. Anatomy. Financial disclosure. Dr. Boraiah Sreeharsha. Nothing to declare

ADRENAL LESIONS 10/09/2012. Adrenal + lesion. Introduction. Common causes. Anatomy. Financial disclosure. Dr. Boraiah Sreeharsha. Nothing to declare ADRENAL LESIONS Financial disclosure Nothing to declare Dr. Boraiah Sreeharsha MBBS;FRCR;FRCPSC Introduction Adrenal + lesion Adrenal lesions are common 9% of the population Increase in the detection rate

More information

How do the Parameters affect Image Quality and Dose for Abdominal CT? Image Review

How do the Parameters affect Image Quality and Dose for Abdominal CT? Image Review How do the Parameters affect Image Quality and Dose for Abdominal CT? Image Review Mannudeep K. Kalra, MD, DNB Massachusetts General Hospital Harvard Medical School Financial Disclosure This presentation

More information

Dual Energy CT of the Heart: Perfusion and Beyond

Dual Energy CT of the Heart: Perfusion and Beyond Dual Energy CT of the Heart: Perfusion and Beyond U. Joseph Schoepf, MD, FAHA, FSCBT MR, FSCCT Professor of Radiology, Medicine, and Pediatrics Director of Cardiovascular Imaging Disclosures Consultant

More information

Workup of a Solid Liver Lesion

Workup of a Solid Liver Lesion Workup of a Solid Liver Lesion Joseph B. Cofer MD FACS Chief Quality Officer Erlanger Health System Affiliate Professor of Surgery UTHSC-Chattanooga I have no financial or other relationships with any

More information

SPECIFIC PRINCIPLES FOR DOSE REDUCTION IN HEAD CT IMAGING. Rajiv Gupta, MD, PhD Neuroradiology, Massachusetts General Hospital Harvard Medical School

SPECIFIC PRINCIPLES FOR DOSE REDUCTION IN HEAD CT IMAGING. Rajiv Gupta, MD, PhD Neuroradiology, Massachusetts General Hospital Harvard Medical School SPECIFIC PRINCIPLES FOR DOSE REDUCTION IN HEAD CT IMAGING Rajiv Gupta, MD, PhD Neuroradiology, Massachusetts General Hospital Harvard Medical School OUTLINE 1 st Presentation: Dose optimization strategies

More information

NONINVASIVE IMAGING METHODS FOR ASSESSMENT OF LIVER DAMAGE IN NASH

NONINVASIVE IMAGING METHODS FOR ASSESSMENT OF LIVER DAMAGE IN NASH NONINVASIVE IMAGING METHODS FOR ASSESSMENT OF LIVER DAMAGE IN NASH Bachir Taouli, MD Director of Body MRI and Cancer Imaging Program Department of Radiology / Translational and Molecular Imaging Institute

More information

A study on CT pulmonary angiography at low kv and low-concentration contrast medium using iterative reconstruction.

A study on CT pulmonary angiography at low kv and low-concentration contrast medium using iterative reconstruction. Biomedical Research 2017; 28 (17): 7683-7687 ISSN 0970-938X www.biomedres.info A study on CT pulmonary angiography at low kv and low-concentration contrast medium using iterative reconstruction. Yanhe

More information

HCC RADIOLOGIC DIAGNOSIS

HCC RADIOLOGIC DIAGNOSIS UCSF Transplant 2010 THE BEFORE AND AFTER HEPATOCELLULAR CARCINOMA MANAGEMENT Francis Yao, M.D. Professor of Clinical Medicine and Surgery Medical Director, Liver Transplantation University of California,

More information

New Technologies for Cardiac CT. Geoffrey D. Rubin, MD, MBA, FACR, FNASCI Duke University

New Technologies for Cardiac CT. Geoffrey D. Rubin, MD, MBA, FACR, FNASCI Duke University 1996 New Technologies for Cardiac CT Geoffrey D. Rubin, MD, MBA, FACR, FNASCI Duke University New Technology The Long View Levels of Efficacy Endpoint Examples 1: Technical Imaging resolution 2: Diagnostic

More information

Simon Nepveu 1, Irina Boldeanu 1, Yves Provost 1, Jean Chalaoui 1, Louis-Mathieu Stevens 2,3, Nicolas Noiseux 2,3, Carl Chartrand-Lefebvre 1,3

Simon Nepveu 1, Irina Boldeanu 1, Yves Provost 1, Jean Chalaoui 1, Louis-Mathieu Stevens 2,3, Nicolas Noiseux 2,3, Carl Chartrand-Lefebvre 1,3 Coronary Artery Bypass Graft Imaging with CT Angiography and Iterative Reconstruction: Quantitave Evaluation of Radiation Dose Reduction and Image Quality Simon Nepveu 1, Irina Boldeanu 1, Yves Provost

More information

What s New in Breast Imaging. Jennifer A. Harvey, M.D., FACR Professor of Radiology University of Virginia

What s New in Breast Imaging. Jennifer A. Harvey, M.D., FACR Professor of Radiology University of Virginia What s New in Breast Imaging Jennifer A. Harvey, M.D., FACR Professor of Radiology University of Virginia Disclosure Hologic, Inc. Shareholder and research agreement. Volpara Solutions, Ltd. Shareholder

More information

Yoshihisa Tsuji, Naoki Takahashi, Joel G. Fletcher, David M. Hough, Brendan P. McMenomy, Cynthia H McCollough, Katharine L. Grant, Ernst Klotz

Yoshihisa Tsuji, Naoki Takahashi, Joel G. Fletcher, David M. Hough, Brendan P. McMenomy, Cynthia H McCollough, Katharine L. Grant, Ernst Klotz Prediction of pancreatic necrosis in early stage of acute pancreatitis using subtraction color map images created from contrast-enhanced and unenhanced CT. Yoshihisa Tsuji, Naoki Takahashi, Joel G. Fletcher,

More information

Learning Objectives. After attending this presentation, participants will be able to:

Learning Objectives. After attending this presentation, participants will be able to: Learning Objectives After attending this presentation, participants will be able to: Describe HCV in 2015 Describe how to diagnose advanced liver disease and cirrhosis Identify the clinical presentation

More information

CT Perfusion. U. Joseph Schoepf, MD, FAHA, FSCBT MR, FSCCT Professor of Radiology, Medicine, and Pediatrics Director of Cardiovascular Imaging

CT Perfusion. U. Joseph Schoepf, MD, FAHA, FSCBT MR, FSCCT Professor of Radiology, Medicine, and Pediatrics Director of Cardiovascular Imaging CT Perfusion U. Joseph Schoepf, MD, FAHA, FSCBT MR, FSCCT Professor of Radiology, Medicine, and Pediatrics Director of Cardiovascular Imaging Disclosures Consultant for / research support from Bayer Bracco

More information

Dual-Energy CT Applications in the Abdomen

Dual-Energy CT Applications in the Abdomen Dual-Energy CT Review Dual-Energy CT Review Tobias Heye 1 Rendon C. Nelson Lisa M. Ho Daniele Marin Daniel T. Boll Heye T, Nelson RC, Ho LM, Marin D, Boll DT Keywords: abdomen, dual-energy CT, iodine extraction,

More information

CTA/MRA of Pediatric Hepatic Masses Radiology-Pathology Correlation

CTA/MRA of Pediatric Hepatic Masses Radiology-Pathology Correlation Acta Radiológica Portuguesa, Vol.XVIII, nº70, pág. 41-50, Abr.-Jun., 2006 CTA/MRA of Pediatric Hepatic Masses Radiology-Pathology Correlation Marilyn J. Siegel Mallinckrodt Institute of Radiology, Washington

More information

Low Dose Era in Cardiac CT

Low Dose Era in Cardiac CT Low Dose Era in Cardiac CT DIANA E. LITMANOVICH, MD Department of Radiology Beth Israel Deaconess Medical Center Harvard Medical School Disclosures Neither I nor my immediate family members have a financial

More information

Spectral CT imaging as a new quantitative tool? Assessment of perfusion defects of pulmonary parenchyma in patients with lung cancer

Spectral CT imaging as a new quantitative tool? Assessment of perfusion defects of pulmonary parenchyma in patients with lung cancer Original Article Spectral CT imaging as a new quantitative tool? Assessment of perfusion defects of pulmonary parenchyma in patients with lung cancer Ying-Shi Sun, Xiao-Yan Zhang, Yong Cui, Lei Tang, Xiao-Ting

More information

9/10/2018. Liver Transplant for Hepatocellular Carcinoma (HCC): What is New? DISCLOSURES

9/10/2018. Liver Transplant for Hepatocellular Carcinoma (HCC): What is New? DISCLOSURES UCSF Transplant 2018: Pioneering Advances in Transplantation DISCLOSURES Liver Transplant for Hepatocellular Carcinoma (HCC): What is New? I have no relevant commercial interests or relationships to report

More information

Liver imaging the revolution

Liver imaging the revolution Liver imaging the revolution Valérie Vilgrain Hôpital Beaujon, Paris, France PHC 2018 - www.aphc.info At the Beginning of the story Radiology in the 1970s US Garrett Radiology 1976 abscess Taylor Radiology

More information

Liver transplantation: Hepatocellular carcinoma

Liver transplantation: Hepatocellular carcinoma Liver transplantation: Hepatocellular carcinoma Alejandro Forner BCLC Group. Liver Unit. Hospital Clínic. University of Barcelona 18 de marzo 2015 3r Curso Práctico de Transplante de Órganos Sólidos Barcelona

More information

Guidelines for SIRT in HCC An Evolution

Guidelines for SIRT in HCC An Evolution Guidelines for SIRT in HCC An Evolution 2 nd Asia Pacific Symposium on Liver- Directed Y-90 Microspheres Therapy 1st November 2014, Singapore The challenge of HCC Surgery is potentially curative in early

More information

COLORECTAL CANCER STAGING in 2010

COLORECTAL CANCER STAGING in 2010 COLORECTAL CANCER STAGING in 2010 Robert A. Halvorsen, MD, FACR MCV Hospitals / VCU Medical Center Richmond, Virginia I do not have any relevant financial relationships with any commercial interests COLON

More information

Imaging Pancreatic Neuroendocrine Tumors (PNETs): CT, MRI, EUS, Nuclear

Imaging Pancreatic Neuroendocrine Tumors (PNETs): CT, MRI, EUS, Nuclear Imaging Pancreatic Neuroendocrine Tumors (PNETs): CT, MRI, EUS, Nuclear Eric Tamm, M.D. Department of Diagnostic Radiology Division of Diagnostic Imaging MD Anderson Cancer Center Houston, TX Disclosure

More information

Hepatocellular Carcinoma: Diagnosis and Management

Hepatocellular Carcinoma: Diagnosis and Management Hepatocellular Carcinoma: Diagnosis and Management Nizar A. Mukhtar, MD Co-director, SMC Liver Tumor Board April 30, 2016 1 Objectives Review screening/surveillance guidelines Discuss diagnostic algorithm

More information

Certainty. lives in layers. Philips IQon Spectral CT. Computed tomography

Certainty. lives in layers. Philips IQon Spectral CT. Computed tomography Computed tomography Certainty *The Centers for Medicare & Medicaid Services requires United States hospitals that treat Medicare patients to participate in the national Hospital Consumer Assessment of

More information

Split-bolus spectral CT imaging of the pancreas

Split-bolus spectral CT imaging of the pancreas Split-bolus spectral CT imaging of the pancreas Poster No.: C-2620 Congress: ECR 2012 Type: Scientific Exhibit Authors: O. R. Brook, S. Gourtsoyianni, A. Brook, C. Wilcox, B. 1 1 2 1 1 1 1 2 Siewert, V.

More information

Evaluation of energy spectrum CT for the measurement of thyroid iodine content

Evaluation of energy spectrum CT for the measurement of thyroid iodine content Shao et al. BMC Medical Imaging (2016) 16:47 DOI 10.1186/s12880-016-0151-y RESEARCH ARTICLE Open Access Evaluation of energy spectrum CT for the measurement of thyroid iodine content Weiguang Shao, Jingang

More information

Alessandro Albonico Philips

Alessandro Albonico Philips Alessandro Albonico Philips Alessandro.albonico@philips.com Noise (Standard Deviation in HU) Virtually noise-free Characteristic of a true knowledge-based IR 80 70 Standard Recon idose4 Level6 1 mm Slice

More information

CT & MRI of Benign Liver Neoplasms Srinivasa R Prasad

CT & MRI of Benign Liver Neoplasms Srinivasa R Prasad CT & MRI of Benign Liver Neoplasms Srinivasa R Prasad No financial disclosures Acknowledgements Many thanks to Drs. Heiken, Narra & Menias (MIR) Dr. Sahani (MGH) for sharing images Benign Liver Tumors:

More information

True Dual Energy. Dr. Stefan Ulzheimer, Siemens Healthcare GmbH. DEfinitely Siemens

True Dual Energy. Dr. Stefan Ulzheimer, Siemens Healthcare GmbH. DEfinitely Siemens DEfinitely Siemens True Dual Energy Dr. Stefan Ulzheimer, Siemens Healthcare GmbH International version. Not for distribution in the US. Unrestricted Siemens AG 2015 All rights reserved. The products/features

More information

Surveillance for HCC Who, how Diagnosis of HCC Surveillance for HCC in Practice

Surveillance for HCC Who, how Diagnosis of HCC Surveillance for HCC in Practice Surveillance for Hepatocellular Carcinoma Hashem B. El-Serag, MD, MPH Dan L. Duncan Professor of Medicine Chief, Gastroenterology and Hepatology Houston VA & Baylor College of Medicine Houston, TX Outline

More information

Liver Tumors. Prof. Dr. Ahmed El - Samongy

Liver Tumors. Prof. Dr. Ahmed El - Samongy Liver Tumors Prof. Dr. Ahmed El - Samongy Objective 1. Identify the most important features of common benign liver tumors 2. Know the risk factors, diagnosis, and management of hepatocellular carcinoma

More information

Radiology of hepatobiliary diseases

Radiology of hepatobiliary diseases GI cycle - Lecture 14 436 Teams Radiology of hepatobiliary diseases Objectives 1. To Interpret plan x-ray radiograph of abdomen with common pathologies. 2. To know the common pathologies presentation.

More information

Quantitatively Defining Washout in Hepatocellular Carcinoma

Quantitatively Defining Washout in Hepatocellular Carcinoma Gastrointestinal Imaging Original Research Kamaya et al. Washout in Hepatocellular Carcinoma Gastrointestinal Imaging Original Research Yueyi I. Liu 1 Lewis K. Shin 1,2 R. Brooke Jeffrey 1 Aya Kamaya 1

More information

Biomarkers and the Future of. John R. Votaw CBIS 5 th Year Anniversary Celebration/Look to the future February 8, 2013

Biomarkers and the Future of. John R. Votaw CBIS 5 th Year Anniversary Celebration/Look to the future February 8, 2013 Biomarkers and the Future of Radiology John R. Votaw CBIS 5 th Year Anniversary Celebration/Look to the future February 8, 2013 Statistics/Radiology Collaboration The utility of Radiologic procedures

More information

University of Groningen. Quantitative CT myocardial perfusion Pelgrim, Gert

University of Groningen. Quantitative CT myocardial perfusion Pelgrim, Gert University of Groningen Quantitative CT myocardial perfusion Pelgrim, Gert IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF) if you wish to cite from it. Please check

More information

Newcastle HPB MDM updated radiology imaging protocol recommendations. Author Dr John Scott. Consultant Radiologist Freeman Hospital

Newcastle HPB MDM updated radiology imaging protocol recommendations. Author Dr John Scott. Consultant Radiologist Freeman Hospital Newcastle HPB MDM updated radiology imaging protocol recommendations Author Dr John Scott. Consultant Radiologist Freeman Hospital This document is intended as a guide to aid radiologists and clinicians

More information

Evangelos Chartampilas Bioclinic Hospital Thessaloniki, Greece

Evangelos Chartampilas Bioclinic Hospital Thessaloniki, Greece Evangelos Chartampilas Bioclinic Hospital Thessaloniki, Greece Hepatospecificcontrast agents Gadobenate dimeglumine (Multihance) Gadoxeticacid (Primovist) 3-5% liver uptake 50% liver uptake Hepatobiliary

More information

Ultralow Dose Chest CT with MBIR

Ultralow Dose Chest CT with MBIR Ultralow Dose Chest CT with MBIR Ella A. Kazerooni, M.D. Professor & Director Cardiothoracic Radiology Associate Chair for Clinical Affairs University of Michigan Disclosures Consultant: GE Healthcare

More information

Scientific Exhibit. Authors: D. Takenaka, Y. Ohno, Y. Onishi, K. Matsumoto, T.

Scientific Exhibit. Authors: D. Takenaka, Y. Ohno, Y. Onishi, K. Matsumoto, T. The feasibility of biphasic contrast-media-injection-protocol for chest imaging on 320-slice volume MDCT: Direct comparison of biphasic and bolus contrast-media injection protocols on 320-slice volume

More information

Hepatocellular carcinoma (HCC) is a malignant liver neoplasm

Hepatocellular carcinoma (HCC) is a malignant liver neoplasm Diagn Interv Radiol 2011; 17:328 333 Turkish Society of Radiology 2011 ABDOMINAL IMAGING ORIGINAL ARTICLE Correlation of dynamic multidetector CT findings with pathological grades of hepatocellular carcinoma

More information

Monophasic versus biphasic contrast application in CT of patients with head and neck tumour

Monophasic versus biphasic contrast application in CT of patients with head and neck tumour Monophasic versus biphasic contrast application in CT of patients with head and neck tumour Poster No.: C-3331 Congress: ECR 2010 Type: Topic: Authors: Keywords: DOI: Scientific Exhibit Head and Neck G.

More information

Low-Dose CT: Clinical Studies & the Radiologist Perspective

Low-Dose CT: Clinical Studies & the Radiologist Perspective Low-Dose CT: Clinical Studies & the Radiologist Perspective RD-ASiR RD-MBIR SD-FBP RD=0.35 msv (80% dose reduction) Perry J. Pickhardt, MD UW School of Medicine & Public Health Low-Dose CT: Clinical Overview

More information

How to evaluate tumor response? Yonsei University College of Medicine Kim, Beom Kyung

How to evaluate tumor response? Yonsei University College of Medicine Kim, Beom Kyung How to evaluate tumor response? Yonsei University College of Medicine Kim, Beom Kyung End points in research for solid cancers Overall survival (OS) The most ideal one, but requires long follow-up duration

More information

Liver Transplantation for HCC Which Criteria?

Liver Transplantation for HCC Which Criteria? Liver Transplantation for HCC Which Criteria? Jacques Belghiti - François Durand Claire Francoz Hepato-Biliary-Pancreatic Liver Surgery and Liver Transplantation Unit Hôpital Beaujon (AP-HP), Clichy -

More information

EASL-EORTC Guidelines

EASL-EORTC Guidelines Pamplona, junio de 2008 CLINICAL PRACTICE GUIDELINES: PARADIGMS IN MANAGEMENT OF HCC EASL-EORTC Guidelines Bruno Sangro Clínica Universidad de Navarra. CIBERehd. Pamplona, Spain Levels of Evidence according

More information

5/26/10. Oren Fix, MD, MSc Transplant Hepatology Division of Gastroenterology University of California San Francisco

5/26/10. Oren Fix, MD, MSc Transplant Hepatology Division of Gastroenterology University of California San Francisco Oren Fix, MD, MSc Transplant Hepatology Division of Gastroenterology University of California San Francisco Epidemiology Surveillance Biomarkers Biopsy Treatment Resec@on, local regional therapy, radioemboliza@on,

More information

Acknowledgements. Update of Focal Liver Lesions Goals. Focal Liver Lesions. Imaging Choices For Liver Lesions. Focal Liver Lesions

Acknowledgements. Update of Focal Liver Lesions Goals. Focal Liver Lesions. Imaging Choices For Liver Lesions. Focal Liver Lesions Acknowledgements Update of Focal Liver Lesions 2012 Giles Boland Massachusetts General Hospital Harvard Medical School No disclosures Dushyant Sahani Mukesh Harisinghani Goals Focal liver lesions Imaging

More information

Breast CT and Dosimetry

Breast CT and Dosimetry 2013 ICTP/IAEA Training Course on Radiation Protection of Patients Trieste Breast CT and Dosimetry John M. Boone, Ph.D., FAAPM, FSBI, FACR Professor and Vice Chair (Research) of Radiology Professor of

More information

Pediatric chest HRCT using the idose 4 Hybrid Iterative Reconstruction Algorithm: Which idose level to choose?

Pediatric chest HRCT using the idose 4 Hybrid Iterative Reconstruction Algorithm: Which idose level to choose? Journal of Physics: Conference Series PAPER OPEN ACCESS Pediatric chest HRCT using the idose 4 Hybrid Iterative Reconstruction Algorithm: Which idose level to choose? To cite this article: M Smarda et

More information

STANDARDIZED MANAGEMENT RECOMMENDATIONS FOR ADRENAL NODULES: EVIDENCE-BASED CONSENSUS POWERSCRIBE MACROS FROM AN ACADEMIC/PRIVATE PRACTICE

STANDARDIZED MANAGEMENT RECOMMENDATIONS FOR ADRENAL NODULES: EVIDENCE-BASED CONSENSUS POWERSCRIBE MACROS FROM AN ACADEMIC/PRIVATE PRACTICE STANDARDIZED MANAGEMENT RECOMMENDATIONS FOR ADRENAL NODULES: EVIDENCE-BASED CONSENSUS POWERSCRIBE MACROS FROM AN ACADEMIC/PRIVATE PRACTICE COLLABORATIVE Pamela Johnson 1, Darcy Wolfman 2, Upma Rawal 3,

More information

Objectives. HCC Incidence and Mortality. Disclosure Statement HCC. Imaging of Hepatocellular Carcinoma. Treatment of Hepatocellular Carcinoma

Objectives. HCC Incidence and Mortality. Disclosure Statement HCC. Imaging of Hepatocellular Carcinoma. Treatment of Hepatocellular Carcinoma Imaging of Hepatocellular Carcinoma and the use of LI RADS Treatment of Hepatocellular Carcinoma Aaron D. Anderson, D.O. AOCR April 2015 Objectives Show how the use of LI RADS can simplify the diagnosis

More information

MRI for HCC surveillance and reporting: LI-RADS. Donald G. Mitchell, M.D. Thomas Jefferson University Philadelphia, PA

MRI for HCC surveillance and reporting: LI-RADS. Donald G. Mitchell, M.D. Thomas Jefferson University Philadelphia, PA MRI for HCC surveillance and reporting: LI-RADS Donald G. Mitchell, M.D. Thomas Jefferson University Philadelphia, PA Cirrhotic Nodules Regenerative Nodule Atypical Nodule Hyperplastic Nodule Dysplastic

More information

To Shield or Not to Shield? Lincoln L. Berland, M.D.

To Shield or Not to Shield? Lincoln L. Berland, M.D. To Shield or Not to Shield? Lincoln L. Berland, M.D. Disclosures Consultant to: Nuance, Inc. Page 2 Breast Radiation on CT Use of chest CT has increased in women vulnerable to cancer induction by radiation.

More information

Liver MRI in 30 minutes

Liver MRI in 30 minutes X Liver MRI in 30 minutes SCBT/MR Annual Meeting Salt Lake City September 18, 2016 Scott B. Reeder, MD, PhD Department of Radiology University of Wisconsin Madison, WI Disclosures University of Wisconsin-Madison

More information

UMHS-PUHSC JOINT INSTITUTE

UMHS-PUHSC JOINT INSTITUTE Role of Visceral Adiposity in the Pathogenesis of Non-Alcoholic Fatty Liver Disease in Lean versus Obese Patients: A Comparative Study between Patients at UMHS versus PUHSC Lai WEI and Anna LOK W Zhang,

More information

Abdominal Solid Organ Injury

Abdominal Solid Organ Injury Abdominal Solid Organ Injury 9th Nordic Trauma Radiology Course Aarhus, Denmark May 23-26, 2016 K.SHANMUGANATHAN M.D. ABDOMINAL TRAUMA OBJECTIVES Splenic injury Late arterial / early p-v phase imaging

More information

Ask EuroSafe Imaging. Tips & Tricks. CT Working Group

Ask EuroSafe Imaging. Tips & Tricks. CT Working Group Ask EuroSafe Imaging Tips & Tricks CT Working Group The use of bi-phase injection protocols to reduce the number of acquisition phases and radiation dose Alban Gervaise (Medical Imaging Department, HIA

More information

Dr Claire Smith, Consultant Radiologist St James University Hospital Leeds

Dr Claire Smith, Consultant Radiologist St James University Hospital Leeds Dr Claire Smith, Consultant Radiologist St James University Hospital Leeds Imaging in jaundice and 2ww pathway Image protocol Staging Limitations Pancreatic cancer 1.2.4 Refer people using a suspected

More information

Abdominal Solid Organ Injury

Abdominal Solid Organ Injury Abdominal Solid Organ Injury 8 th Nordic Course Stockholm, Sweden May 19-22, 2014 K.SHANMUGANATHAN M.D. ABDOMINAL TRAUMA OBJECTIVES Splenic injury Late arterial / early p-v phase imaging Liver injury Blunt

More information

Information for patients (and their families) waiting for liver transplantation

Information for patients (and their families) waiting for liver transplantation Information for patients (and their families) waiting for liver transplantation Waiting list? What is liver transplant? Postoperative conditions? Ver.: 5/2017 1 What is a liver transplant? Liver transplantation

More information